| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
15 |
6 |
p. 693-696
|
artikel
|
| 2 |
A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping
|
Louveau, Baptiste
|
|
|
15 |
6 |
p. 759-771
|
artikel
|
| 3 |
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
|
Fisher, Julie G.
|
|
|
15 |
6 |
p. 733-741
|
artikel
|
| 4 |
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study
|
Faloppi, Luca
|
|
|
15 |
6 |
p. 801-802
|
artikel
|
| 5 |
Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3
|
Lüftner, Diana
|
|
|
15 |
6 |
p. 805
|
artikel
|
| 6 |
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
|
Niederwieser, Dietger
|
|
|
15 |
6 |
p. 807
|
artikel
|
| 7 |
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
|
Ramanathan, Ramesh K.
|
|
|
15 |
6 |
p. 803
|
artikel
|
| 8 |
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
|
Orsi, Giulia
|
|
|
15 |
6 |
p. 809-810
|
artikel
|
| 9 |
Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
|
Scott, Lesley J.
|
|
|
15 |
6 |
p. 791-799
|
artikel
|
| 10 |
Everolimus in Advanced Breast Cancer: A Systematic Review and Meta-analysis
|
Raphael, Jacques
|
|
|
15 |
6 |
p. 723-732
|
artikel
|
| 11 |
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
|
Sigorski, Dawid
|
|
|
15 |
6 |
p. 709-722
|
artikel
|
| 12 |
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
|
Orsi, Giulia
|
|
|
15 |
6 |
p. 773-785
|
artikel
|
| 13 |
Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
|
Chong, Li Chia
|
|
|
15 |
6 |
p. 751-757
|
artikel
|
| 14 |
SB8: A Bevacizumab Biosimilar
|
Syed, Yahiya Y.
|
|
|
15 |
6 |
p. 787-790
|
artikel
|
| 15 |
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
|
Al Baghdadi, Tareq
|
|
|
15 |
6 |
p. 743-750
|
artikel
|
| 16 |
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
|
Theodoropoulos, Nicholas
|
|
|
15 |
6 |
p. 697-708
|
artikel
|
Tijdschrift beschrijving